ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
13.50
-1.37 (-9.21%)
Aug 22, 2025, 4:00 PM - Market closed
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $1.33 billion as of August 22, 2025. Its market cap has increased by 43.88% in one year.
Market Cap
1.33B
Enterprise Value
1.17B
1-Year Change
43.88%
Ranking
Category
Stock Price
$13.50
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $1.33B, an increase of 134.78%. That is a compound annual growth rate of 35.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 1.33B | 30.12% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 644.97B |
| Johnson & Johnson | 428.48B |
| AbbVie | 366.44B |
| UnitedHealth Group | 280.44B |
| AstraZeneca | 250.88B |
| Novartis AG | 246.51B |
| Novo Nordisk | 246.31B |
| Abbott Laboratories | 228.65B |